Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
AxoGen Inc - SIC # 3845 - ELECTROMEDICAL AND ELECTROTHERAPEUTIC APPARATUS
Ticker
Exchange
SIC #
Website
Latest Ticker
AXGN
Nasdaq
3845
https://www.axogeninc.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for AxoGen Inc
AxoGen First Quarter 2024 Earnings: Misses Expectations
- May 3rd, 2024 11:31 am
Axogen Inc (AXGN) Q1 2024 Earnings Call Transcript Highlights: Navigating Growth Amidst Challenges
- May 3rd, 2024 7:02 am
AxoGen (AXGN) Reports Q1 Loss, Lags Revenue Estimates
- May 2nd, 2024 12:15 pm
Axogen, Inc Reports First Quarter 2024 Financial Results
- May 2nd, 2024 11:00 am
AxoGen, Inc. (NASDAQ:AXGN) is largely controlled by institutional shareholders who own 58% of the company
- May 1st, 2024 2:07 pm
Axogen Announces First Surgical Implants of Avive+ Soft Tissue Matrix™
- Apr 29th, 2024 8:50 pm
Axogen, Inc. to Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024
- Apr 16th, 2024 11:00 am
Analysts Expect Breakeven For AxoGen, Inc. (NASDAQ:AXGN) Before Long
- Apr 4th, 2024 12:01 pm
Director Gregory Freitag Sells 25,000 Shares of Axogen Inc (AXGN)
- Mar 9th, 2024 4:55 am
US$13.80 - That's What Analysts Think AxoGen, Inc. (NASDAQ:AXGN) Is Worth After These Results
- Mar 8th, 2024 10:37 am
AxoGen, Inc. (NASDAQ:AXGN) Q4 2023 Earnings Call Transcript
- Mar 6th, 2024 1:20 pm
AxoGen Full Year 2023 Earnings: Beats Expectations
- Mar 6th, 2024 12:37 pm
Q4 2023 AxoGen Inc Earnings Call
- Mar 6th, 2024 2:27 am
Axogen Inc (AXGN) Reports Growth in Revenue and Reduction in Net Loss for Q4 and Full-Year 2023
- Mar 5th, 2024 12:31 pm
Axogen, Inc Reports 2023 Fourth Quarter and Full-Year Financial Results
- Mar 5th, 2024 12:00 pm
Zacks.com featured highlights Protagonist Therapeutics, AxoGen, Western Digital and Phunware
- Mar 5th, 2024 9:43 am
Ekso Bionics (EKSO) Reports Q4 Loss, Tops Revenue Estimates
- Mar 4th, 2024 10:20 pm
AxoGen (AXGN) Is a Great Choice for 'Trend' Investors, Here's Why
- Feb 28th, 2024 1:50 pm
AxoGen, Inc. (AXGN) Hit a 52 Week High, Can the Run Continue?
- Feb 26th, 2024 2:15 pm
Zacks.com featured highlights AxoGen, Western Digital and Gen Digital
- Feb 20th, 2024 10:06 am
Scroll